HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Norbert Gattermann Selected Research

Iron Overload

12/2021The Evaluation of Iron Deficiency and Iron Overload
1/2020Do Recent Randomized Trial Results Influence which Patients with Myelodysplastic Syndromes Receive Iron Chelation?
1/2018Iron overload in myelodysplastic syndromes (MDS).
3/2016New insights into transfusion-related iron toxicity: Implications for the oncologist.
12/2013When is iron overload deleterious, and when and how should iron chelation therapy be administered in myelodysplastic syndromes?
1/2013Geographical variations in current clinical practice on transfusions and iron chelation therapy across various transfusion-dependent anaemias.
8/2012Improved survival in MDS patients receiving iron chelation therapy - a matched pair analysis of 188 patients from the Düsseldorf MDS registry.
1/2012Pathophysiological and clinical aspects of iron chelation therapy in MDS.
1/2011Iron overload in MDS-pathophysiology, diagnosis, and complications.
7/2009The treatment of secondary hemochromatosis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Norbert Gattermann Research Topics

Disease

46Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2021 - 11/2002
15Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2020 - 11/2002
12Iron Overload
12/2021 - 12/2007
10Anemia
12/2021 - 07/2006
9Neoplasms (Cancer)
12/2021 - 11/2002
9BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2021 - 11/2002
4Refractory Anemia with Excess of Blasts (RAEM)
12/2013 - 02/2004
4Refractory Anemia
07/2012 - 01/2002
3Cytopenia
04/2010 - 01/2002
2Inflammation (Inflammations)
12/2021 - 12/2013
2Hemochromatosis (Bronze Diabetes)
12/2021 - 07/2009
2Thrombosis (Thrombus)
08/2021 - 05/2016
2Philadelphia Chromosome
07/2017 - 11/2007
2Leukemia
05/2016 - 01/2003
2Exanthema (Rash)
03/2012 - 02/2008
2Thalassemia
01/2012 - 07/2009
2Myeloproliferative Disorders (Myeloproliferative Disorder)
05/2008 - 11/2005
2Blast Crisis (Blast Phase)
12/2006 - 01/2003
1Iron-Refractory Iron Deficiency Anemia
12/2021
1Chronic Disease (Chronic Diseases)
12/2021
1Iron Deficiencies
12/2021
1Acquired Immunodeficiency Syndrome (AIDS)
12/2021
1Hypertension (High Blood Pressure)
08/2021
1Disease Progression
07/2017
1Carcinogenesis
03/2016
1Hyperferritinemia
12/2013
1Polycythemia (Erythrocytosis)
08/2012
1Aneurysm (Aneurysms)
08/2012
1Thrombocytosis (Thrombocythemia)
07/2012
1Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
02/2012
1Hemosiderosis
04/2010
1Thrombocytopenia (Thrombopenia)
11/2009
1Hemorrhage
07/2008
1Uniparental Disomy
07/2008
1Systemic Mastocytosis
07/2008
1Mitochondrial Diseases (Mitochondrial Disease)
05/2008
1Acute Promyelocytic Leukemia
11/2007

Drug/Important Bio-Agent (IBA)

20IronIBA
12/2021 - 01/2002
9Azacitidine (5 Azacytidine)FDA Link
06/2018 - 03/2009
6nilotinibFDA Link
01/2021 - 11/2007
6DeferasiroxFDA Link
10/2015 - 02/2008
5Valproic Acid (Depakote)FDA LinkGeneric
08/2011 - 09/2004
4HepcidinsIBA
12/2021 - 12/2013
4Pharmaceutical PreparationsIBA
03/2012 - 03/2009
4Imatinib Mesylate (Gleevec)FDA Link
01/2011 - 12/2006
4bcr-abl Fusion ProteinsIBA
01/2011 - 12/2006
3HematinicsIBA
10/2019 - 01/2016
3Lenalidomide (CC 5013)FDA Link
01/2019 - 09/2015
3Ferritins (Ferritin)IBA
12/2013 - 04/2010
3Chelating AgentsIBA
03/2012 - 04/2010
3Cytarabine (Cytosar-U)FDA LinkGeneric
04/2010 - 12/2006
3Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2006 - 09/2004
3Histone Deacetylases (Histone Deacetylase)IBA
01/2006 - 09/2004
2Biological ProductsIBA
10/2020 - 02/2012
2Janus Kinase 2IBA
07/2012 - 11/2005
2CreatinineIBA
03/2012 - 02/2008
2N 30IBA
02/2012 - 02/2008
2Dietary IronIBA
01/2012 - 01/2011
2Mitochondrial DNA (mtDNA)IBA
06/2011 - 05/2008
1Chimeric Antigen ReceptorsIBA
12/2021
1Interleukin-6 (Interleukin 6)IBA
12/2021
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
08/2021
1Uric Acid (Urate)IBA
08/2021
1luspaterceptIBA
01/2021
1Proteins (Proteins, Gene)FDA Link
10/2020
1Biomarkers (Surrogate Marker)IBA
05/2016
1TransferasesIBA
05/2016
1Reactive Oxygen Species (Oxygen Radicals)IBA
03/2016
1C-Reactive ProteinIBA
12/2013
1Hemoglobins (Hemoglobin)IBA
12/2013
1ErythropoietinFDA Link
12/2013
1Transferrin (beta 2 Transferrin)IBA
12/2013
1Transferrin Receptors (Transferrin Receptor)IBA
12/2013
1hemoglobin YorkIBA
08/2012
1Oxygen (Dioxygen)IBA
08/2012
1DecitabineFDA Link
11/2009
1tipifarnib (R115777)IBA
11/2009
1Amino AcidsFDA Link
02/2009
1beta 2-Microglobulin (beta 2 Microglobulin)IBA
02/2009
1Hemostatics (Antihemorrhagics)IBA
07/2008
1Heparin (Liquaemin)FDA LinkGeneric
07/2008
1DNA (Deoxyribonucleic Acid)IBA
07/2008
1AnticoagulantsIBA
07/2008
1DiamondIBA
02/2008
1ArsenicIBA
11/2007
1Arsenic Trioxide (Trisenox)FDA Link
11/2007

Therapy/Procedure

19Therapeutics
12/2021 - 12/2006
10Chelation Therapy (Therapy, Chelation)
09/2019 - 12/2007
8Drug Therapy (Chemotherapy)
12/2018 - 11/2002
5Stem Cell Transplantation
01/2020 - 11/2002
4Erythrocyte Transfusion
01/2019 - 07/2008
2Blood Transfusion (Blood Transfusions)
12/2021 - 01/2011
2Hematopoietic Stem Cell Transplantation
03/2016 - 05/2009
1Immunotherapy
12/2021
1Drug Tapering
01/2019
1Surgical Instruments (Clip)
08/2012
1Chemoradiotherapy
02/2012
1Induction Chemotherapy
02/2012
1Cell Transplantation
01/2010
1Platelet Transfusion (Blood Platelet Transfusions)
11/2009